Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201111165 Principal Investigator: Roth, Bruce
Title: A Phase 3, randomized, double-blind, controlled trial of cabozantinib (XL184) vs. mitoxantrone plus prednisone in men with previously treated symptomatic castration-resistant prostate cancer
Phase: III Disease Site: Prostate
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to see if cabozantinib is effective in reducing pain for patients with prostate cancer compared with mitoxantrone plus prednisone.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)